Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 34

1.

Optical Properties and Growth Mechanism of La3Ga5.5Nb0.5O14 Macroporous Ceramic.

Hsiao YJ, Nagarjuna Y, Wang SC.

Nanoscale Res Lett. 2019 Aug 16;14(1):282. doi: 10.1186/s11671-019-3104-x.

2.

Functional Correlates of Resting-State Connectivity in the Default Mode Network of Heroin Users on Methadone Treatment and Medication-Free Therapeutic Community Program.

Kuo LW, Lin PS, Lin SY, Liu MF, Jan H, Lee HC, Wang SC.

Front Psychiatry. 2019 Jun 6;10:381. doi: 10.3389/fpsyt.2019.00381. eCollection 2019.

3.

GRK5 Is Associated with the Regulation of Methadone Dosage in Heroin Dependence.

Wang SC, Chung RH, Kuo HW, Liu TH, Fang CP, Liu SC, Liu CC, Tsou HH, Chen ACH, Liu YL.

Int J Neuropsychopharmacol. 2018 Oct 1;21(10):910-917. doi: 10.1093/ijnp/pyy066.

4.

Resolution of transmission electron backscatter diffraction in aluminum and silver: Effect of the atomic number.

Kuo CW, Kuo JC, Wang SC.

Ultramicroscopy. 2018 Oct;193:126-136. doi: 10.1016/j.ultramic.2018.06.019. Epub 2018 Jun 30.

PMID:
30005322
5.

APBB2 is associated with amphetamine use and plasma beta-amyloids in patients receiving methadone maintenance treatment.

Liu CC, Fang CP, Liu TH, Kuo HW, Liu SC, Wang SC, Chen ACH, Liu YL.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Apr 20;83:92-98. doi: 10.1016/j.pnpbp.2018.01.008. Epub 2018 Jan 10.

PMID:
29330135
6.

Inflammatory chemokine eotaxin-1 is correlated with age in heroin dependent patients under methadone maintenance therapy.

Kuo HW, Liu TH, Tsou HH, Hsu YT, Wang SC, Fang CP, Liu CC, Chen ACH, Liu YL.

Drug Alcohol Depend. 2018 Feb 1;183:19-24. doi: 10.1016/j.drugalcdep.2017.10.014. Epub 2017 Nov 28.

PMID:
29222992
7.

Missense mutation at CLDN8 associated with a high plasma interferon gamma-inducible protein 10 level in methadone-maintained patients with urine test positive for morphine.

Liu TH, Chung RH, Wang SC, Fang CP, Tsou HH, Shih CL, Kuo HW, Wang Y, Liu YL.

PLoS One. 2017 Nov 16;12(11):e0187639. doi: 10.1371/journal.pone.0187639. eCollection 2017.

8.

Comparative risk of seizure with use of first- and second-generation antipsychotics in patients with schizophrenia and mood disorders.

Wu CS, Wang SC, Yeh IJ, Liu SK.

J Clin Psychiatry. 2016 May;77(5):e573-9. doi: 10.4088/JCP.15m09898.

PMID:
27249081
9.
10.

Haplotypes of the D-Amino Acid Oxidase Gene Are Significantly Associated with Schizophrenia and Its Neurocognitive Deficits.

Liu YL, Wang SC, Hwu HG, Fann CS, Yang UC, Yang WC, Hsu PC, Chang CC, Wen CC, Tsai-Wu JJ, Hwang TJ, Hsieh MH, Liu CC, Chien YL, Fang CP, Faraone SV, Tsuang MT, Chen WJ, Liu CM.

PLoS One. 2016 Mar 17;11(3):e0150435. doi: 10.1371/journal.pone.0150435. eCollection 2016.

11.

A Room Temperature H₂ Sensor Fabricated Using High Performance Pt-Loaded SnO₂ Nanoparticles.

Wang SC, Shaikh MO.

Sensors (Basel). 2015 Jun 17;15(6):14286-97. doi: 10.3390/s150614286.

12.

Chemokine IP-10 is correlated with cardiac responses and status of infection with HIV and HCV in methadone maintenance patients.

Liu SW, Liu YL, Hwang LL, Wang SC, Kuo HW, Wu SL, Dai YW, Liu SC, Ho IK, Chen AC, Hsiao CF, Tsou HH.

Int J Cardiol. 2015 Sep 1;194:36-8. doi: 10.1016/j.ijcard.2015.05.055. Epub 2015 May 12. No abstract available.

PMID:
26011262
13.

Concordance between patient self-reports and claims data on clinical diagnoses, medication use, and health system utilization in Taiwan.

Wu CS, Lai MS, Gau SS, Wang SC, Tsai HJ.

PLoS One. 2014 Dec 2;9(12):e112257. doi: 10.1371/journal.pone.0112257. eCollection 2014.

14.
15.

Pharmacogenomics study in a Taiwan methadone maintenance cohort.

Wang SC, Tsou HH, Ho IK, Lin KM, Liu YL.

J Food Drug Anal. 2013 Dec;21(4):S62-S68.

16.

Assessment of CYP450 genetic variability effect on methadone dose and tolerance.

Tsai HJ, Wang SC, Liu SW, Ho IK, Chang YS, Tsai YT, Lin KM, Liu YL.

Pharmacogenomics. 2014 May;15(7):977-86. doi: 10.2217/pgs.14.19.

PMID:
24956251
17.

The association of genetic polymorphisms in the κ-opioid receptor 1 gene with body weight, alcohol use, and withdrawal symptoms in patients with methadone maintenance.

Wang SC, Tsou HH, Chung RH, Chang YS, Fang CP, Chen CH, Ho IK, Kuo HW, Liu SC, Shih YH, Wu HY, Huang BH, Lin KM, Chen AC, Hsiao CF, Liu YL.

J Clin Psychopharmacol. 2014 Apr;34(2):205-11. doi: 10.1097/JCP.0000000000000082.

PMID:
24525640
18.

Functional genetic polymorphisms in CYP2C19 gene in relation to cardiac side effects and treatment dose in a methadone maintenance cohort.

Wang SC, Ho IK, Tsou HH, Liu SW, Hsiao CF, Chen CH, Tan HK, Lin L, Wu CS, Su LW, Huang CL, Yang YH, Liu ML, Lin KM, Liu SC, Wu HY, Kuo HW, Chen AC, Chang YS, Liu YL.

OMICS. 2013 Oct;17(10):519-26. doi: 10.1089/omi.2012.0068. Epub 2013 Sep 9.

19.

Hepatitis C virus infection influences the S-methadone metabolite plasma concentration.

Wu SL, Wang SC, Tsou HH, Kuo HW, Ho IK, Liu SW, Hsu YT, Chang YS, Liu YL.

PLoS One. 2013 Jul 23;8(7):e69310. doi: 10.1371/journal.pone.0069310. Print 2013.

20.

PXR polymorphisms interacted with CYP2B6 polymorphisms on methadone metabolites.

Tsai HJ, Wang SC, Tian JN, Chang TK, Ho IK, Hsiao CF, Chen CH, Tan HK, Lin L, Wu CS, Su LW, Huang CL, Yang YH, Liu ML, Lin KM, Liu YL.

J Clin Psychopharmacol. 2013 Feb;33(1):137-40. doi: 10.1097/01.jcp.0000426186.34421.de. No abstract available.

PMID:
23288240

Supplemental Content

Loading ...
Support Center